Michael Singer

Michael Singer has over 25 years of experience in the healthcare industry. Michael is currently a Strategic Advisory Board Member at iVexSol. Michael has also served on the Board of Advisors for Medumo and Thirsty Brook Investments.

Singer began their career as a research scientist at Yale University. Michael then transitioned to the biotech industry, holding positions at Cartesian Therapeutics, Pykus Therapeutics, and BioPorto Diagnostics A/S. In 2016, they joined Within Health as CEO. Michael led the company through its acquisition by Anodyne Nanotech, Inc in 2019.

Singer has a proven track record of success in the healthcare industry. Michael is an expert in strategic planning, business development, and fundraising. Michael has a deep understanding of the ever-changing healthcare landscape and is well-positioned to help iVexSol continue to grow and succeed.

Michael Singer attended Yale University for their undergraduate, medical, and PhD studies in biology, medicine, and neuroscience respectively. Michael then completed an internship/residency in internal medicine and ophthalmology at Harvard Medical School. Michael is certified by the Commonwealth of Massachusetts in medical license and by the USPTO in registered patent agent.